US Patent Issued to PRESCIENCE BIOTECHNOLOGY on Oct. 7 for "Liposome comprising rapamycin or a derivative thereof and use thereof in therapy" (Taiwanese Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,874, issued on Oct. 7, was assigned to PRESCIENCE BIOTECHNOLOGY INC. (Taipei, Taiwan).

"Liposome comprising rapamycin or a derivative thereof and use thereof in therapy" was invented by Tzu-Ying Tseng (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a lipid-based formulation comprising rapamycin and derivatives thereof, and also relates to using the formulation for treatment of diseases or conditions, such as cancers, immuo-related disease, etc."

The patent was filed on April 28, 2022, under Application No. 17/661,153.

*For further information, including images, charts and tables, please visit: http:/...